Anti-TIF-1γ autoantibodies (also anti-TRIM33 or anti-p155/140 autoantibodies) were first described in 2006 when a large cohort of patients with idiopathic inflammatory myopathies was examined by immunoprecipitation (IP) (1). The gene discussed is TRIM33; the disease is idiopathic inflammatory myopathy.